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Abstract
Introduction: A limitation for investigating the pathophysiological role of neutrophils in vivo is the
lack of a reliable biomarker for neutrophil cytotoxicity in the liver. Therefore, we investigated if
immunohistochemical detection of chlorotyrosine protein adducts can be used as a specific
footprint for generation of neutrophil-derived hypochlorous acid in vivo.
Methods: C3Heb/FeJ mice were treated with 100 micrograms/kg endotoxin (ET) alone or in
combination with 700 mg/kg galactosamine (Gal/ET). Some animals received additionally two doses
of 10 mg/kg of the pancaspase inhibitor Z-VAD-fmk. An antibody against chlorotyrosine was used
for the immunohistochemical analysis.
Results: At 6 h after Gal/ET, hepatocellular apoptosis was evident without increase in plasma ALT
activities. Neutrophils accumulated in sinusoids but there was no evidence for chlorotyrosine
staining. At 7 h after Gal/ET, about 54% of the sequestered neutrophils had extravasated, there was
extensive necrosis and increased plasma ALT activities. Extensive immunostaining for
chlorotyrosine, mainly colocalized with neutrophils, could be observed. Treatment with Z-VAD-
fmk eliminated apoptosis, necrosis and the increase in plasma ALT values. Neutrophil extravasation
was prevented but the overall number of neutrophils in the liver was unchanged. Chlorotyrosine
staining was absent in these samples. After ET alone (7 h), sinusoidal neutrophil accumulation was
similar to Gal/ET treatment but there was no apoptosis, neutrophil extravasation, ALT release or
chlorotyrosine staining.
Conclusions: Chlorotyrosine staining in liver samples correlated well with evidence of neutrophil-
induced liver injury in the endotoxemia model. These results indicate that assessment of
chlorotyrosine protein adduct formation by immunohistochemistry could be a useful marker of
neutrophil-induced liver cell injury in vivo.
Introduction
Neutrophils are involved in the pathophysiology of
hepatic ischemia-reperfusion injury, endotoxin- and sep-
sis-induced liver failure, alcoholic hepatitis, and certain
drug toxicities [1]. Prerequisite for neutrophil cytotoxicity
is the accumulation in sinusoids, extravasation and the
adherence to the parenchymal cells [2]. Neutrophils cause
cell injury by generation of reactive oxygen species and
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protease release [3-6]. A limitation for investigating the
pathophysiological role of neutrophils in vivo is the lack of
a reliable biomarker for neutrophil cytotoxicity in the
liver. Neutrophils generate superoxide with NADPH oxi-
dase. They also release myeloperoxidase at the same time
and, therefore, form hypochlorous acid as a major oxidant
[7]. Hypochlorous acid is a potent chlorinating agent
which can cause the formation of chlorotyrosine protein
adducts [7]. Antibodies can be generated to detect chloro-
tyrosine in the tissue [8,9]. However, this approach has
never been validated in models of neutrophil-induced
liver injury in vivo. Therefore, we investigated if immuno-
histochemical detection of chlorotyrosine protein adducts
can be used as a specific footprint for generation of neu-
trophil-derived hypochlorous acid in vivo. To test this
hypothesis, we used the well-characterized model of
galactosamine/endotoxin (Gal/ET)-induced liver injury,
where neutrophil cytotoxicity aggravates the initial apop-
totic injury [10], by a reactive oxygen-dependent mecha-
nism [3].
Results and Discussion
Neutrophil accumulation in the hepatic sinusoids and
extravasation into the parenchymal tissue has been shown
to occur after Gal/ET treatment in mice [2,4]. In our study,
immunohistochemical analysis of liver sections showed
that neutrophils accumulated in the livers after Gal/ET
treatment (6 h: 202 ± 21 per 10 high power fields, HPF; 7
h: 343 ± 28 per 10 HPF). At 6 h most of these neutrophils
(about 90%) remained in the sinusoids. The plasma
alanine transaminase (ALT) activities at this time did not
increase over controls. However, by 7 h post-treatment,
over 50% of the neutrophils present in the livers had
extravasated into the parenchyma (Table 1). The plasma
ALT activities increased 20-fold over untreated controls
(Table 1). Histological evaluation of necrosis in hematox-
ylin and eosin (H&E)-stained sections revealed 45%
necrotic hepatocytes at 7 h compared to 15% at 6 h (Table
1).
Liver sections were immunostained with a rabbit anti-
chlorotyrosine antibody to assess the formation of chloro-
tyrosine-protein adducts in the liver. No positive staining
was observed in control livers (Figure 1) or after Gal/ET 6
h (Table 1). After Gal/ET treatment for 7 h, the liver sec-
tions showed extensive positive staining for the adducts
inside the hepatocytes as well as along the sinusoids (Fig-
ure 1). Moreover, sequential staining with the anti-chloro-
tyrosine and -Gr1 antibodies of the same liver sections
showed co-localization of the chlorotyrosine adducts with
the extravasated neutrophils. On the other hand, liver sec-
tions of mice treated with endotoxin alone for 7 h (ET 7
h) showed only slight positive staining in the sinusoids.
Gal/ET treatment causes caspase activation and hepatocel-
lular apoptosis [10]. To confirm this, hepatic caspase-3
activities were measured using a synthetic fluorogenic cas-
pase-3 substrate, Ac-DEVD-MCA. Compared to controls,
caspase-3 activities increased by 365-fold and 600-fold at
6 h and 7 h, respectively. Hepatocellular apoptosis was
quantified, using morphological criteria, in liver sections
stained with the terminal deoxynucleotidyl transferase-
mediated dUTP nick end labeling (TUNEL) assay, and
expressed as a percentage of the total cells evaluated
[11,12]. Apoptotic cells were rare in control livers
(<0.1%). After Gal/ET treatment, hepatocellular apoptosis
increased to 13% at 6 h and 19% at 7 h.
If parenchymal cell apoptosis is prevented by various cas-
pase inhibitors [10] or by injection of endotoxin without
galactosamine [2], transmigration of neutrophils does not
occur and any injury is eliminated. Therefore, in order to
investigate the effect of a pancaspase inhibitor on neu-
trophil-induced cytotoxicity and chlorotyrosine adduct
formation, animals were treated with Z-VAD-fmk in addi-
tion to Gal/ET. Z-VAD reduced the hepatic caspase-3 activ-
ities to baseline and the hepatocellular apoptosis at 6 and
7 h by 90%. It also reduced the number of extravasated
neutrophils in the tissue and liver cell injury (plasma ALT
Table 1: Neutrophil extravasation, liver injury and chlorotyrosine adduct formation during murine endotoxemia.
Number of Extravasated 
Neutrophils (per 10 HPF)
Plasma ALT Activities (U/L) Necrosis (%) Chlorotyrosine Staining 
(Intensity)
Controls 0 ± 0 64 ± 16 0 ± 0 0
Gal/ET 6 h 23 ± 3 41 ± 9 15 ± 2* 0
Gal/ET 6 h + ZVAD 6 ± 2 18 ± 13 2 ± 1# 0
Gal/ET 7 h 186 ± 30*,$ 1252 ± 369*,$ 45 ± 2*,$ ++++
Gal/ET 7 h + ZVAD 19 ± 5# 10 ± 3# 3 ± 1# +
Animals were sacrificed 6 or 7 h after Gal/ET treatment. Some animals received 2 doses of the pancaspase inhibitor ZVAD (10 mg/kg) at 3 and 4.5 
h. Alanine aminotransferase (ALT) activities were measured in plasma. Liver sections were immunostained with the anti-Gr1 and anti-
chlorotyrosine antibodies for evaluation of neutrophil extravasation and chlorotyrosine adduct formation, respectively. Necrosis was estimated in 
sections stained with H&E. Data represent means ± SE of n = 4 animals per group. *P < 0.05 (compared to controls) $P < 0.05 (compared to Gal/
ET6 h) #P < 0.05 (compared to Gal/ET alone).Comparative Hepatology 2004, 3 http://www.comparative-hepatology.com/content/3/S1/S48
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and necrosis) at 7 h, by 90% (Table 1). This was accompa-
nied by reduced immunostaining for chlorotyrosine
adducts inside the hepatocytes. Only mild positive stain-
ing was observed in the sinusoids around the neutrophils.
However, the pancaspase inhibitor did not affect the total
number of neutrophils accumulated in the livers at both
time points, i.e., 6 h and 7 h after Gal/ET.
These data show that the formation of chlorotyrosine pro-
tein adducts closely follows the extravasation of neu-
trophils (Gal/ET 7 h). Protein adduct formation also
correlated well with the dramatic increase in the plasma
ALT levels and liver cell necrosis as indicators for cytotox-
icity of neutrophils. These findings are consistent with the
hypothesis that the activated neutrophils generated
hypochlorous acid. In contrast, no adducts were formed
during the early phase of the apoptotic injury, i.e., when
90% of the neutrophils in the liver remained inactive in
the sinusoids (Gal/ET 6 h). Likewise, no protein adducts
were formed when the neutrophils were primed but not
fully activated (ET 7 h), or when the chemotactic signal for
neutrophil extravasation was removed by elimination of
the apoptotic cell injury (Gal/ET 7 h + ZVAD). Neu-
trophils can mediate tissue injury either through reactive
oxygen species or the release of proteases [3-6]. In this
regard, our study further supports the role of reactive oxy-
gen species, and hypochlorous acid in particular, in neu-
trophil-induced cytotoxicity in vivo.
Chlorotyrosine-protein adduct formation in the liver Figure 1
Chlorotyrosine-protein adduct formation in the liver. Liver sections were immunostained with an anti-chlorotyrosine 
antibody to assess the formation of chlorotyrosine-protein adducts after galactosamine/endotoxin treatment. No staining was 
observed in livers from untreated controls (A). After Gal/ET treatment for 7 h, the liver sections showed extensive positive 
staining for adducts inside hepatocytes as well as along sinusoids (B).
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Conclusions
Chlorotyrosine-protein adducts are formed in the liver
during murine endotoxemia, a well-established model of
neutrophil-induced liver injury in vivo. These adducts can
be easily and reliably detected through immunohisto-




Male C3Heb/FeJ mice (Jackson Laboratories, Bar Harbor,
ME) were treated i.p. with 100 micrograms/kg Salmonella
abortus equi endotoxin (ET) alone or in combination with
700 mg/kg galactosamine (Gal/ET; Sigma Chemical Co.,
St. Louis, MO). Animals were sacrificed 6 or 7 h after treat-
ment. Some animals received additionally two 10 mg/kg
doses of the pancaspase inhibitor Z-VAD-fmk (Enzyme
Systems Products, Dublin, CA) at 3 and 4.5 h after Gal/ET.
An antibody against chlorotyrosine was generated by
standard procedures and used for the immunohistochem-
ical analysis [13]. The following parameters were meas-
ured as previously described: caspase-3 activity [10], DNA
strand breaks with terminal deoxynucleotidyl transferase-
mediated dUTP nick end labeling (TUNEL staining)
[11,12], neutrophil localization (anti-Gr1 immunostain-
ing), plasma ALT activities [10], imunohistochemistry for
chlorotyrosine adducts, and histological assessment of
necrosis in liver sections stained with H&E [11,12].
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